Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).
Asou N, Adachi K, Tamura U, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama U, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake H, Ohno R.
Asou N, et al. Among authors: ohtake h.
Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S65-71. doi: 10.1007/s002800100308.
Cancer Chemother Pharmacol. 2001.
PMID: 11587370
Clinical Trial.